8-K
filed May 16, 2024, 7:59 PM ET
ticker BCYC
CIK 0001761612
other
confidence high
sentiment neutral
materiality 0.15
Bicycle Therapeutics shareholders approve all 11 proposals at 2024 AGM
BICYCLE THERAPEUTICS PLC
- Directors Kevin Lee (36.4M for) and Jose-Carlos Gutierrez-Ramos (35.0M for) re-elected.
- Advisory vote on executive compensation passed with 36.2M for, 1.2M against.
- Ratification of PwC as US and UK auditors approved with ~37.4M for each.
- Share allotment authorization and pre-emption rights disapplication passed with >32M for each.
- New articles of association adopted with 37.4M for, 15,138 against.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To approve the directors' remuneration report for the year ended December 31, 2023. at the 2024-05-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 8 – To approve the directors’ remuneration report for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,200,790 1,188,057 9,260
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To adopt the new articles of association in substitution for, and to the exclusion of, the Company's existing articles of association. at the 2024-05-16 meeting.
- Proposal
- charter amendment
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 11 – To adopt the new articles of association in substitution for, and to the exclusion of, the Company’s existing articles of association. For Against Vote Withheld/Abstain 37,371,711 15,138 11,258
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Audit Committee of the Company's Board of Directors to determine the Company's U.K. statutory auditors' remuneration for the year ending December 31, 2024. at the 2024-05-16 meeting.
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 6 – To authorize the Audit Committee of the Company’s Board of Directors (the “Board”) to determine the Company’s U.K. statutory auditors’ remuneration for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,455 14,150 7,502
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Company's definitive proxy statement. at the 2024-05-16 meeting.
- Proposal
- say on pay
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s definitive proxy statement. For Against Vote Withheld/Abstain 36,186,115 1,202,477 9,515
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. at the 2024-05-16 meeting.
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 10 – To authorize the Board to allot equity securities for cash up to a maximum aggregate nominal amount of £1,000,000 pursuant to the authorization in Resolution 9 as if U.K. statutory pre-emption rights did not apply. For Against Vote Withheld/Abstain 32,350,797 4,154,715 892,595
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. at the 2024-05-16 meeting.
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 9 – To authorize the Board to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to a maximum aggregate nominal amount of £1,000,000. For Against Vote Withheld/Abstain 33,241,556 4,146,578 9,973
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2024. at the 2024-05-16 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 4 – To ratify the appointment of PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.S. independent registered public accounting firm for the year ending December 31, 2024. For Against Vote Withheld/Abstain 37,376,526 14,076 7,505
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Kevin Lee. at the 2024-05-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 1 – To re-elect as a director Kevin Lee. For Against Vote Withheld/Abstain 36,413,260 977,286 7,561
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To receive and adopt the Company's U.K. statutory annual accounts and reports for the year ended December 31, 2023. at the 2024-05-16 meeting.
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 7 – To receive and adopt the Company’s U.K. statutory annual accounts and reports for the year ended December 31, 2023. For Against Vote Withheld/Abstain 36,494,043 896,166 7,898
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To re-elect as a director Jose-Carlos Gutierrez-Ramos. at the 2024-05-16 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 2 – To re-elect as a director Jose-Carlos Gutierrez-Ramos. For Against Vote Withheld/Abstain 35,019,069 2,371,385 7,653
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
BICYCLE THERAPEUTICS PLC shareholders approved To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. at the 2024-05-16 meeting.
- Outcome
- passed
- Meeting
- 2024-05-16
Exact text from the filing
Proposal 5 – To re-appoint PricewaterhouseCoopers LLP, a limited liability partnership organized under the laws of England, as the Company’s U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders. For Against Vote Withheld/Abstain 37,376,531 14,071 7,505
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.